Johnson and Johnson 2005 Annual Report Download - page 10

Download and view the complete annual report

Please find page 10 of the 2005 Johnson and Johnson annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 80

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80

PAGE 8 JOHNSON & JOHNSON 2005 ANNUAL REPORT
Advancing the standards of care and bringing forward new modalities of surgical
treatments and breakthrough products help improve outcomes for more patients.
Left: Prof. Elio Franco, director of
vascular surgery, Gaetano Rummo
City Hospital, Benevento, Italy,
discusses ETHICON OMNEX™ Surgical
Sealant, a synthetic, biodegradable
material that mechanically seals
blood vessels and artificial grafts
to prevent blood leakage after
traditional suturing.
Right: The Stroke Management
Group, which is an internal strategic
initiative comprised of representa-
tion from 19 Johnson & Johnson
companies, is collaborating to bring
stroke victims new treatment options
such as ST. JOSEPH® 81mg Adult
Regimen Aspirin from McNeil
Consumer Healthcare Division of
McNeil-PPC, Inc. for secondary
stroke prevention and development
programs in carotid artery and
intracranial stenting. The group has
also worked with health care leaders
such as Joseph Broderick, M.D.,
stroke expert and chief of neurology
at the University of Cincinnati Medical
Center, to help change the way stroke
treatment is reimbursed in the U.S.
The effort has laid a foundation for
new therapies and enables hospitals
and providers to improve the quality
of care for stroke patients such as
David Reichert. Stroke is the third
leading cause of death in the U.S.
Below: The Johnson & Johnson
Medical (China) Ltd. Science
Center in Beijing is dedicated to
professional health care education
and academic exchange.